Ischemic preconditioning in solid organ transplantation: from experimental to clinics

Joan Torras Ambros1, Immaculada Herrero-Fresneda, Oscar Gulias Borau

  • 1Department of Medicine, Laboratory of Nephrology and Nephrology Service, IDIBELL-Hospital Universitari Bellvitge, University of Barcelona, Barcelona, Spain. 15268jta@comb.es

Summary

Ischemic preconditioning (IP) protects organs from ischemia-reperfusion injury by altering metabolism and reducing inflammation. While effective in animal models, more human research is needed for clinical applications like transplantation.